Mross, K., 		Frost, A., 		Scheulen, M., 		Krauss, J., 		Strumberg, D., 		Schultheiss, B., 		Fasol, U., 		Büchert, M., 		Krätzschmer, J., 		Delesen, H., 		Rajagopalan, P., & 		Christensen, O.
2011 Jul 29.  Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer. Vascular Cell. [Online] 3:1